Literature DB >> 22482767

Underuse of curative surgery for early stage upper gastrointestinal cancers in the United States.

Lee J McGhan1, David A Etzioni, Richard J Gray, Barbara A Pockaj, Kathryn E Coan, Nabil Wasif.   

Abstract

BACKGROUND: Surgery is the cornerstone of potentially curative therapy for upper gastrointestinal cancer. We analyzed the patterns of treatment regarding the use of surgery for early-stage upper gastrointestinal cancer in the United States.
METHODS: The Surveillance, Epidemiology, and End Research database was used to identify patients with cancer of the esophagus, stomach, pancreas, liver, gallbladder, biliary tract, or duodenum (2004-2007). Only patients with potentially resectable stage I and II disease were selected. The primary outcome measure was the use of curative intent surgery. The secondary outcomes were the predictors of surgery.
RESULTS: We identified 29,249 patients with a median age of 69 years. Only 54% of the patients underwent cancer-directed surgical resection, ranging from 28% for liver cancer to 89% for gallbladder cancer. The remaining patients underwent either local excision (8%) or no surgery (38%). Among the no surgery group, most patients (79%) were documented as "not being recommended for resection." The independent variables on multivariate analysis predictive of a nonoperative approach included black race, age older than 75 years, tumor size greater than 5 cm, and high poverty level (P < 0.001). Patients who did not undergo surgery had worse median and overall survival at 3 years than patients undergoing surgery (11 months versus 36 months and 14% versus 43%, respectively; P < 0.001).
CONCLUSIONS: Almost one half of patients with early-stage upper gastrointestinal cancer did not receive potentially curative surgery, with an adverse effect on overall survival. A combination of demographic, tumor, and socioeconomic factors were predictive of a lack of surgical resection.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22482767     DOI: 10.1016/j.jss.2012.03.013

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital.

Authors:  Ryan Morgan; Michael Cassidy; Susanna W L DeGeus; Jennifer Tseng; David McAneny; Teviah Sachs
Journal:  J Gastrointest Surg       Date:  2018-08-10       Impact factor: 3.452

2.  Trends in racial disparities in pancreatic cancer surgery.

Authors:  Anand Shah; K S Clifford Chao; Truls Ostbye; Anthony W Castleberry; Ricardo Pietrobon; Beat Gloor; Bryan M Clary; Rebekah R White; Mathias Worni
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

3.  Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration.

Authors:  Jonathan Pastrana Del Valle; Nathanael R Fillmore; George Molina; Mark Fairweather; Jiping Wang; Thomas E Clancy; Stanley W Ashley; Richard D Urman; Edward E Whang; Jason S Gold
Journal:  Ann Surg Oncol       Date:  2022-01-10       Impact factor: 5.344

4.  Medicaid expansion and the management of pancreatic cancer.

Authors:  Richard S Hoehn; Caroline J Rieser; Heather Phelos; Lindsay M Sabik; Ibrahim Nassour; Sidrah Khan; Christof Kaltenmeier; Alessandro Paniccia; Amer H Zureikat; Samer T Tohme
Journal:  J Surg Oncol       Date:  2021-05-03       Impact factor: 2.885

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.